Bax expression in untreated breast cancer: An immunocytometric study of 255 cases

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2595-2598

  Martinez Arribas F ^a   Martin Garabato E ^a   Zapardiel, I ^b   Sanchez J ^a,c   Lucas, A R ^a   Tejerina, A ^a   Schneider, J ^a,d  

^a Fundacion Tejerina   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Bax; Breast cancer; Immunocytometry; Nup88

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN NUP 88; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; NUCLEAR PORE COMPLEX PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55749098497     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kumar R, Vadlamudi RK and Adam L: Apoptosis in mammary gland and cancer. Endocrine-Related Cancer 7: 257-269, 2000.
2. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
3. Reed JC: Balancing cell life and death: apoptosis and breast cancer. J Clin Invest 97: 2403-2404, 1996.
4. Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, Arnold W, Dietel M, Guski H, Feller A, Royer HD and Dörken B: Overexpression of the death-promoting gene bax-alpha which is down-regulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 97: 2651-2659, 1996.
5. Martinez-Arribas F, Nuñez-Villar MJ, Lucas AR, Sanchez J, Tejerina A and Schneider J: Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Anticancer Res 23: 565-568, 2003.
6. Agudo D, Gómez-Esquer F, Martínez-Arribas F, Núñez-Villar MJ, Pollán M and Schneider J: Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109: 717-720, 2004.
7. Bastos R, Ribas DP, Enarson M, Bodoor K and Burke B: Nup84, a novel nucleoporin that is asociated with CAN/Nup214 on the cytoplasmic face of the nuclear pore complex. J Cell Biol 137: 989-1000, 1997.
8. Fornerod M, Boer J, Van Baal S, Morreau H and Grosveld G: Interaction of cellular proteins with the leukemia-specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene 13: 1801-1808, 1996.
9. Martínez N, Alonso A, Moragues D, Pontón J and Schneider J: The nuclear pore complex protein Nup88 is overexpressed by tumor cells. Cancer Res 59: 5408-5411, 1999.
10. Zhang H, Schneider J and Rosdahl I: Expression of p16, p27, p53 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol 21: 43-48, 2002.
11. Emterling A, Skoglund J, Arbman G, Zhang H, Schneider J, Evertson S, Carstensen J and Sun XF: Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology 64: 361-369, 2003.
12. Boer J, Bonten-Surtel J and Grosveld G: Overexpression of the nucleoporin CAN/Nup214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 18: 1236-1247, 1998.
13. Shu W, Chen Y, Wu Q, Li R and Cui G: Deguelin represses both the expression of nucleophosmin and some nucleoporins: Nup88 and Nup214 in Jurkat cells. Biol Pharm Bull 31: 27-32, 2008.
14. Martínez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R and Schneider J: Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem 97: 1275-1282, 2006.
15. Gómez-Esquer F, Agudo D, Martínez-Arribas F, Núñez-Villar MJ, Pollán M and Schneider J: The X-chromosome RBMX gene is expressed in mammary carcinoma. Cancer Genomics Proteomics 1: 39-44, 2004.
16. Martínez-Arribas F, Núñez-Villar MJ, Lucas AR, Tejerina A and Schneider J: Immunfluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Anticancer Res 23: 565-568, 2003.